{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:40:37Z","timestamp":1768797637029,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11095-008-9629-9","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T17:32:29Z","timestamp":1212514349000},"page":"1948-1955","source":"Crossref","is-referenced-by-count":31,"title":["Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil"],"prefix":"10.1007","volume":"25","author":[{"given":"Manuela","family":"Banciu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond M.","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,4]]},"reference":[{"key":"9629_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/hyb.1997.16.119","volume":"16","author":"G. Storm","year":"1997","unstructured":"G. Storm, and D. J. Crommelin. Colloidal systems for tumor targeting. Hybridoma. 16:119\u2013125 (1997).","journal-title":"Hybridoma"},{"key":"9629_CR2","first-page":"223","volume":"7","author":"A. A. Gabizon","year":"2001","unstructured":"A. A. Gabizon. Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. Clin Cancer Res. 7:223\u2013225 (2001).","journal-title":"Clin Cancer Res"},{"key":"9629_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1593\/neo.04340","volume":"7","author":"R. M. Schiffelers","year":"2005","unstructured":"R. M. Schiffelers, J. M. Metselaar, M. H. Fens, A. P. Janssen, G. Molema, and G. Storm. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia. 7:118\u2013127 (2005).","journal-title":"Neoplasia"},{"key":"9629_CR4","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.4049\/jimmunol.166.12.7571","volume":"166","author":"R. Salcedo","year":"2001","unstructured":"R. Salcedo, H. A. Young, M. L. Ponce, J. M. Ward, H. K. Kleinman, W. J. Murphy, and J. J. Oppenheim. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol. 166:7571\u20137578 (2001).","journal-title":"J Immunol"},{"key":"9629_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00262-001-0254-2","volume":"51","author":"M. Reale","year":"2002","unstructured":"M. Reale, R. Intorno, R. Tenaglia, C. Feliciani, R. C. Barbacane, A. Santoni, and P. Conti. Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy. Cancer Immunol Immunother. 51:91\u201398 (2002).","journal-title":"Cancer Immunol Immunother"},{"key":"9629_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.186.1.147","volume":"186","author":"L. Biancone","year":"1997","unstructured":"L. Biancone, A. D. Martino, V. Orlandi, P. G. Conaldi, A. Toniolo, and G. Camussi. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J Exp Med. 186:147\u2013152 (1997).","journal-title":"J Exp Med"},{"key":"9629_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.03.019","volume":"113","author":"M. Banciu","year":"2006","unstructured":"M. Banciu, R. M. Schiffelers, M. H. Fens, J. M. Metselaar, and G. Storm. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. J Control Release. 113:1\u20138 (2006).","journal-title":"J Control Release"},{"key":"9629_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/14737140.2.2.143","volume":"2","author":"T. Tejada-Berges","year":"2002","unstructured":"T. Tejada-Berges, C. O. Granai, M. Gordinier, and W. Gajewski. Caelyx\/Doxil for the treatment of metastatic ovarian and breast cancer. Expert Rev Anticancer Ther. 2:143\u2013150 (2002).","journal-title":"Expert Rev Anticancer Ther"},{"key":"9629_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ijc.2910610520","volume":"61","author":"T. Daemen","year":"1995","unstructured":"T. Daemen, G. Hofstede, M. T. Ten Kate, I. A. Bakker-Woudenberg, and G. L. Scherphof. Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages. Int J Cancer. 61:716\u2013721 (1995).","journal-title":"Int J Cancer"},{"key":"9629_CR10","first-page":"111","volume":"4","author":"G. Storm","year":"1998","unstructured":"G. Storm, M. T. ten Kate, P. K. Working, and I. A. Bakker-Woudenberg. Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system. Clin Cancer Res. 4:111\u2013115 (1998).","journal-title":"Clin Cancer Res"},{"key":"9629_CR11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","volume":"95","author":"S. M. Zeisberger","year":"2006","unstructured":"S. M. Zeisberger, B. Odermatt, C. Marty, A. H. Zehnder-Fjallman, K. Ballmer-Hofer, and R. A. Schwendener. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer. 95:272\u2013281 (2006).","journal-title":"Br J Cancer"},{"key":"9629_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5173(99)00040-X","volume":"183","author":"C. Oussoren","year":"1999","unstructured":"C. Oussoren, and G. Storm. Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration. Int J Pharm. 183:37\u201341 (1999).","journal-title":"Int J Pharm"},{"key":"9629_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/LPR-120004780","volume":"12","author":"N. Rooijen van","year":"2002","unstructured":"N. van Rooijen, and E. van Kesteren-Hendrikx. Clodronate liposomes: perspectives in research and therapeutics. J Liposome Res. 12:81\u201394 (2002).","journal-title":"J Liposome Res"},{"key":"9629_CR14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1593\/neo.07913","volume":"10","author":"M. Banciu","year":"2008","unstructured":"M. Banciu, J. M. Metselaar, R. M. Schiffelers, and G. Storm. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia. 10:108\u2013117 (2008).","journal-title":"Neoplasia"},{"key":"9629_CR15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02531316","volume":"5","author":"G. Rouser","year":"1970","unstructured":"G. Rouser, S. Fkeischer, and A. Yamamoto. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 5:494\u2013496 (1970).","journal-title":"Lipids"},{"key":"9629_CR16","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.11140","volume":"48","author":"J. M. Metselaar","year":"2003","unstructured":"J. M. Metselaar, M. H. Wauben, J. P. Wagenaar-Hilbers, O. C. Boerman, and G. Storm. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 48:2059\u20132066 (2003).","journal-title":"Arthritis Rheum"},{"key":"9629_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","volume":"174","author":"N. Rooijen Van","year":"1994","unstructured":"N. Van Rooijen and A. Sanders. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 174:83\u201393 (1994).","journal-title":"J Immunol Methods"},{"key":"9629_CR18","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1208\/pt020310","volume":"2","author":"P. Perugini","year":"2001","unstructured":"P. Perugini, I. Genta, B. Conti, T. Modena, and F. Pavanetto. Long-term release of clodronate from biodegradable microspheres. AAPS PharmSciTech. 2:E10 (2001).","journal-title":"AAPS PharmSciTech"},{"key":"9629_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/08982100600851029","volume":"16","author":"R. M. Schiffelers","year":"2006","unstructured":"R. M. Schiffelers, M. Banciu, J. M. Metselaar, and G. Storm. Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer. J Liposome Res. 16:185\u2013194 (2006).","journal-title":"J Liposome Res"},{"key":"9629_CR20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.exphem.2004.08.002","volume":"32","author":"H. Rozemuller","year":"2004","unstructured":"H. Rozemuller, S. Knaan-Shanzer, A. Hagenbeek, L. van Bloois, G. Storm, and A. C. Martens. Enhanced engraftment of human cells in RAG2\/gammac double-knockout mice after treatment with CL2MDP liposomes. Exp Hematol. 32:1118\u20131125 (2004).","journal-title":"Exp Hematol"},{"key":"9629_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(01)00394-5","volume":"255","author":"R. P. Huang","year":"2001","unstructured":"R. P. Huang. Detection of multiple proteins in an antibody-based protein microarray system. J Immunol Methods. 255:1\u201313 (2001).","journal-title":"J Immunol Methods"},{"key":"9629_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0076-6879(83)91014-5","volume":"91","author":"G. L. Peterson","year":"1983","unstructured":"G. L. Peterson. Determination of total protein. Methods Enzymol. 91:95\u2013119 (1983).","journal-title":"Methods Enzymol"},{"key":"9629_CR23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ijc.2910510618","volume":"51","author":"J. Vaage","year":"1992","unstructured":"J. Vaage, E. Mayhew, D. Lasic, and F. Martin. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer. 51:942\u2013948 (1992).","journal-title":"Int J Cancer"},{"key":"9629_CR24","first-page":"6774","volume":"52","author":"S. K. Huang","year":"1992","unstructured":"S. K. Huang, E. Mayhew, S. Gilani, D. D. Lasic, F. J. Martin, and D. Papahadjopoulos. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52:6774\u20136781 (1992).","journal-title":"Cancer Res"},{"key":"9629_CR25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ijc.2910510221","volume":"51","author":"E. G. Mayhew","year":"1992","unstructured":"E. G. Mayhew, D. Lasic, S. Babbar, and F. J. Martin. Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int J Cancer. 51:302\u2013309 (1992).","journal-title":"Int J Cancer"},{"key":"9629_CR26","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/1097-0142(19940301)73:5<1478::AID-CNCR2820730526>3.0.CO;2-1","volume":"73","author":"J. Vaage","year":"1994","unstructured":"J. Vaage, E. Barbera-Guillem, R. Abra, A. Huang, and P. Working. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer. 73:1478\u20131484 (1994).","journal-title":"Cancer"},{"key":"9629_CR27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1189\/jlb.70.4.478","volume":"70","author":"M. Crowther","year":"2001","unstructured":"M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol. 70:478\u2013490 (2001).","journal-title":"J Leukoc Biol"},{"key":"9629_CR28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L. Bingle","year":"2002","unstructured":"L. Bingle, N. J. Brown, and C. E. Lewis. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 196:254\u2013265 (2002).","journal-title":"J Pathol"},{"key":"9629_CR29","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1172\/JCI27648","volume":"116","author":"Y. Luo","year":"2006","unstructured":"Y. Luo, H. Zhou, J. Krueger, C. Kaplan, S. H. Lee, C. Dolman, D. Markowitz, W. Wu, C. Liu, R. A. Reisfeld, and R. Xiang. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 116:2132\u20132141 (2006).","journal-title":"J Clin Invest"},{"key":"9629_CR30","doi-asserted-by":"crossref","first-page":"11238","DOI":"10.1158\/0008-5472.CAN-06-1278","volume":"66","author":"E. Y. Lin","year":"2006","unstructured":"E. Y. Lin, J. F. Li, L. Gnatovskiy, Y. Deng, L. Zhu, D. A. Grzesik, H. Qian, X. N. Xue, and J. W. Pollard. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66:11238\u201311246 (2006).","journal-title":"Cancer Res"},{"key":"9629_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10611869408996810","volume":"2","author":"A. M. Buiting","year":"1994","unstructured":"A. M. Buiting and N. Van Rooijen. Liposome mediated depletion of macrophages: an approach for fundamental studies. J Drug Target. 2:357\u2013362 (1994).","journal-title":"J Drug Target"},{"key":"9629_CR32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jlb.60.2.230","volume":"60","author":"C. B. Schmidt-Weber","year":"1996","unstructured":"C. B. Schmidt-Weber, M. Rittig, E. Buchner, I. Hauser, I. Schmidt, E. Palombo-Kinne, F. Emmrich, and R. W. Kinne. Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. J Leukoc Biol. 60:230\u2013244 (1996).","journal-title":"J Leukoc Biol"},{"key":"9629_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-4165(88)90049-9","volume":"965","author":"G. Storm","year":"1988","unstructured":"G. Storm, P. A. Steerenberg, F. Emmen, M. van Borssum Waalkes, and D. J. Crommelin. Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. Biochim Biophys Acta. 965:136\u2013145 (1988).","journal-title":"Biochim Biophys Acta"},{"key":"9629_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","volume":"42","author":"A. Gabizon","year":"2003","unstructured":"A. Gabizon, H. Shmeeda, and Y. Barenholz. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 42:419\u2013436 (2003).","journal-title":"Clin Pharmacokinet"},{"key":"9629_CR35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)10149-1","volume":"45","author":"F. A. Fornari","year":"1994","unstructured":"F. A. Fornari, J. K. Randolph, J. C. Yalowich, M. K. Ritke, and D. A. Gewirtz. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol. 45:649\u2013656 (1994).","journal-title":"Mol Pharmacol"},{"key":"9629_CR36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M","volume":"85","author":"H. Torisu","year":"2000","unstructured":"H. Torisu, M. Ono, H. Kiryu, M. Furue, Y. Ohmoto, J. Nakayama, Y. Nishioka, S. Sone, and M. Kuwano. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer. 85:182\u2013188 (2000).","journal-title":"Int J Cancer"},{"key":"9629_CR37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1023\/A:1018953810705","volume":"9","author":"M. C. Woodle","year":"1992","unstructured":"M. C. Woodle, G. Storm, M. S. Newman, J. J. Jekot, L. R. Collins, F. J. Martin, and F. C. Szoka Jr. Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. Pharm Res. 9:260\u2013265 (1992).","journal-title":"Pharm Res"},{"key":"9629_CR38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1","volume":"86","author":"Z. Symon","year":"1999","unstructured":"Z. Symon, A. Peyser, D. Tzemach, O. Lyass, E. Sucher, E. Shezen, and A. Gabizon. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer. 86:72\u201378 (1999).","journal-title":"Cancer"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-008-9629-9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T15:10:24Z","timestamp":1738249824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-008-9629-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,4]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9629"],"URL":"https:\/\/doi.org\/10.1007\/s11095-008-9629-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,4]]}}}